PERRIE L RYAN M.D. NPI 1073530432

NPI Details

Perrie L Ryan, M.D. is a hematology and oncology internal medicine in West Columbia, SC with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Perrie L Ryan, M.D. NPI is 1073530432. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Graduation Year:2003

The provider's business location address is:

222 E MEDICAL LN STE 400
WEST COLUMBIA, SC
ZIP 29169-848
Phone: (803) 794-7511
Fax: (803) 794-7751

The NPI 1073530432 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, bevacizumab, 10 mg (HCPCS:J9035)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Magnesium level (HCPCS:83735)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Adrenocorticotropic hormone (acth) level (HCPCS:82024)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Blood creatinine level (HCPCS:82565)
• Automated urinalysis test (HCPCS:81003)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Ct scan of chest without contrast (HCPCS:71250)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 7/15/2006 and was last updated on 11/11/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: